- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 171.06M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $291.89M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $224.07M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $507.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $381.17M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $712.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $544.15M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $759.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $593.2M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.15B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $984.15M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 162.89M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.08M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $42.98M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $458.28M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $456.53M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $53.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$20.47M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$22.53M |